A Hypoxia Signature for Predicting Prognosis and Tumor Immune Microenvironment in Adrenocortical Carcinoma

Figure 2

Application value of the hypoxia-related signature in predicting the outcomes of ACC patients. (a) Heatmap of expressional profiles of 3 hypoxia-associated genes in the high/low-risk group in two cohorts. (b)-(c) the risk score and OS in patients in the high/low-risk group in two cohorts. (d) The death rate in the high/low-risk group. (e) Kaplan–Meier survival analysis of patients in the high/low-risk group.

(a)

(b)

(c)

(d)

(e)